Gepirone vs Placebo in Treatment of Cocaine Dependence - 3

University of Pennsylvania logo

University of Pennsylvania

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: Gepirone

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000189
K20-00144-3
NIDA-00144-3
3R01DA012268 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.

Enrollment

41 patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems